Pfizer is distributing child resistant pouches for consumers of Nurtec ODT, a prescription migraine medication that was recalled for not fulfilling safety requirements in its packaging, the company and the U.S. Consumer Product Safety Commission said on Thursday.
The recall impacts Nurtec ODT (rimegepant) 75mg orally disintegrating tablets sold in packs containing eight doses on a blister card. Nurtec ODT is a medication prescribed for the acute treatment of migraine attacks and the prevention of episodic migraine in adults, according to Nurtec ODT's website.
According to the CPSC's notice, the packaging of the medication "is not child resistant, posing a risk of poisoning if the contents are swallowed by young children." The agency noted that, per the Poison Prevention Packaging Act, the prescription drugs are required to have child resistant packaging.
A schizo patient can’t differentiate between ideas and thoughts from reality. As a result, they may...
An Indiana board is set to hear allegations Thursday that an Indianapolis doctor should face disciplinary action after...
According to the most recent estimates, more than 65 million people worldwide may be living with...
